HOME >> BIOLOGY >> NEWS
Researchers Demonstrate That COX-2 Inhibits Angiogenisis In Tumor Cells

Aspirin's preventive effects on colon cancer may result from its influence on the development of blood vessels needed for tumor growth, a Vanderbilt Cancer Center researcher reports in the Friday, May 29, issue of the journal Cell.

The work was done jointly by Dr. Raymond N. DuBois, Mina Cobb Wallace Professor of Gastroenterology and Cancer Prevention and director of the division of Gastroenterology, and colleagues at the Osaka University School of Medicine in Japan. The researchers demonstrated two ways in which aspirin can inhibit angiogenesis, an important component in the development and spread of cancer.

"What we found is that NSAIDs can work in two ways -- by inhibiting the enzyme cyclooxygenase-2 (COX-2) in the tumor cells, which then prevents production of factors that prompt angiogenesis, and by inhibiting cyclooxygenase-1 (COX-1) in endothelial cells, which form the blood vessels that grow into the tumor," DuBois said.

The research builds on earlier work by DuBois and his colleagues that suggested aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) help prevent colon cancer by inhibiting COX-2, which they found to be elevated in colon cancer cells.

However, this new research suggests that COX-1 -- and the ability of aspirin and NSAIDs to target it as well -- may also be involved. These studies were carried out in an in vitro model of angiogenesis involving a chamber with colon cancer cells on the bottom and endothelial cells on the top, separated by a porous collagen membrane.

In a series of experiments, the researchers first compared colon cancer cells that overexpress COX-2 to control cells. They found that the COX-2-positive colon carcinoma cells produced angiogenic factors that, in turn, stimulated migration of the endothelial cells across the collagen gel. These COX-2-positive colon cancer cells also prompted the endothelial cells to begin to form tube-like structu
'"/>

Contact: Matt Scanlan
matt.scanlan@mcmail.vanderbilt.edu
(615) 322-4747
Vanderbilt University Medical Center
29-May-1998


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2018)... (PRWEB) , ... August 22, 2018 , ... Lajollacooks4u is proud to have hosted a ... or third time. Companies, such as Illumina, Qualcomm, Hewlett Packard, Sequenom and more, have ... with their teams. , Part of the reason clientele return is due to ...
(Date:8/21/2018)... ... August 20, 2018 , ... ... biopharma R&D, today announced that Seattle-based Aptevo Therapeutics , a clinical-stage ... will use the Genedata Biologics ® platform to facilitate expansion of ...
(Date:8/17/2018)... N.J. and LIEGE, Belgium (PRWEB) , ... ... ... Diagenode today announced the acquisition of NXT-Dx, an established epigenetics service provider ... services including a number of targeted DNA methylation assays using pyrosequencing or ...
Breaking Biology News(10 mins):
(Date:9/7/2018)... ... , ... Now available on live stream, the NanoScientific Symposium on SPM at ... a panel of industry leaders from Harvard, Cornell, RPI, IBM, SUNY and more to ... in the field. Register today to be a part of the nanometrology conference ...
(Date:9/1/2018)... ... August 31, 2018 , ... Rudina Thanasi, a ... a proprietary biofield energy treated nutraceutical supplement used in combating inflammation and autoimmune ... and blood, as well as, organ-specific inflammation. The reported data is as follows: ...
(Date:8/29/2018)... ... August 28, 2018 , ... ... contact lenses, has been ranked in 1138th place on the 27th annual Inc. ... , The list represents the most successful companies within the American economy’s most ...
(Date:8/26/2018)... SEOUL, South Korea (PRWEB) , ... August 24, ... ... a scientific paper on that stem cell-derived exosomes dramatically relieves atopic dermatitis and ... and Therapy. , According to the paper, the symptoms of mice having ...
Breaking Biology Technology:
Cached News: